Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Liu, Qin ^a   Abba, Katharine ^b   Alejandria, Marissa M ^c   Sinclair, David ^b   Balanag, Vincent M ^d   Lansang, Mary Ann D ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^d Lung Center of the Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

DIRECTLY OBSERVED THERAPY; HOME VISIT; HUMAN; NURSING CARE; PATIENT ATTENDANCE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; REMINDER SYSTEM; REVIEW; SYSTEMATIC REVIEW; TELEPHONE CALL; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; ADULT; CHILD; HOSPITAL MANAGEMENT; LATENT TUBERCULOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN TEST; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS, PULMONARY;

ADULT; APPOINTMENTS AND SCHEDULES; CHILD; DIRECTLY OBSERVED THERAPY; HUMANS; LATENT TUBERCULOSIS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMINDER SYSTEMS; SKIN TESTS; TUBERCULOSIS, PULMONARY;

EID: 84922231546     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006594.pub3     Document Type: Review

References (69)

1. Cheng TL, Ottolini MC, Baumhaft K, Brasseux C, Wolf MD, Scheidt PC. Strategies to increase adherence with tuberculosis test reading in a high-risk population. Pediatrics 1997;100(2 Pt 1):210-3.
2. Krishnaswami KV, Somasundaram PR, Tripathy SP, Vaidyanathan B, Radhakrishna S, Fox WA. Randomised study of two policies for managing default in out-patients collecting supplies of drugs for pulmonary tuberculosis in a large city in South India. Tubercle 1981;62(2):103-12.
3. Kunawararak P, Pongpanich S, Chantawong S, Pokaew P, Traisathit P, Srithanaviboonchai K, et al.Tuberculosis treatment with mobile-phone medication reminders in Northern Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 2011;42(6):1444-51.
4. Mohan A, Nassir H, Niazi A. Does routine home visiting improve the return rate and outcome of DOTS patients who delay treatment?. Eastern Mediterranean Health Journal 2003;9(4):702-8.
5. Paramasivan R, Parthasarathy RT, Rajasekaran S. Short course chemotherapy: A controlled study of indirect defaulter retrieval method. Indian Journal of Tuberculosis 1993;40(4):185-90.
6. Roberts MC. Wurtele SK, Leeper JD. Experiments to increase return in a medical screening drive: two futile attempts to apply theory to practice. Social Science & Medicine 1983;17(11):741-6.
7. Roberts MC, Wurtele SK, Leeper JD. Experiments to increase return in a medical screening drive: two futile attempts to apply theory to practice. Social Science & Medicine 1983;17(11):741-6.
8. Salleras Sanmarti L, Alcaide Megias J, Altet Gomez MN, Canela Soler J, Navas Alcala E, Suñe Puigbo MR, et al.Evaluation of the efficacy of health education on the compliance with antituberculosis chemoprophylaxis in school children. A randomized clinical trial. Tubercle and Lung Disease 1993;74(1):28-31.
9. Tanke ED, Leirer VO. Automated telephone reminders in tuberculosis care. Medical Care 1994;32(4):380-9.
10. Ailinger RL, Martyn D, Lasus H, Lima Garcia N. The effect of a cultural intervention on adherence to latent tuberculosis infection therapy in Latino immigrants. Public Health Nursing 2010;27(2):115-20.
11. Akhtar S, Rozi S, White F, Hasan R. Cohort analysis of directly observed treatment outcomes for tuberculosis patients in urban Pakistan. International Journal of Tuberculosis and Lung Disease 2011;15(1):90-6.
12. Alcaide Megías J, Altet Gómez MN, Canela Soler J, Serra Majen L, Garrido Morales P, Navas Alcalá E, et al.Influence of health education on compliance with antituberculous chemoprophylaxis in children: a community trial [Influencia de la educación sanitaria en el cumplimiento de la quimioprofilaxis antituberculosa en niños: ensayo comunitario]. Revista Clínica Española 1990;187(2):89-93.
13. Al-Hajjaj MS, Al-Khatim IM. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. International Journal of Tuberculosis and Lung Disease 2000;4(4):345-9.
14. Alvarez Gordillo GdelC, Alvarez Gordillo JF, Dorantes Jiménez JE. Educational strategy for improving patient compliance with the tuberculosis treatment regimen in Chiapas, Mexico [Estrategia educativa para incrementar el cumplimiento del regimen antituberculoso en Chiapas, Mexico]. Revista Panamericana de Salud Pública 2003;14(6):402-8.
15. Atkins S, Lewin S, Jordaan E, Thorson A. Lay health worker-supported tuberculosis treatment adherence in South Africa: an interrupted time-series study. International Journal of Tuberculosis and Lung Disease 2011;15(1):84-9.
16. Barclay E. Text messages could hasten tuberculosis drug compliance. Lancet 2009;373(9657):15-6.
17. Bordley WC, Margolis PA, Stuart J, Lannon C, Keyes L. Improving preventive service delivery through office systems. Pediatrics 2001;108(3):e41.
18. Bronner LE, Podewils LJ, Peters A, Somnath P, Nshuti L, van der Walt M, et al.Impact of community tracer teams on treatment outcomes among tuberculosis patients in South Africa. BMC Public Health 2012;12:621.
19. Grant AD, Coetzee L, Fielding KL, Lewis JJ, Ntshele S, Luttig MM, et al.'Team up against TB': promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy. AIDS 2010;24(Suppl 5):S37-44.
20. Hovell MF, Sipan CL, Blumberg EJ, Hofstetter CR, Slymen D, Friedman L, et al.Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial. American Journal of Public Health 2003;93(11):1871-7.
21. Hsieh CJ, Lin LC, Kuo BI, Chiang CH, Su WJ, Shih JF. Exploring the efficacy of a case management model using DOTS in the adherence of patients with pulmonary tuberculosis. Journal of Clinical Nursing 2007;17(7):869-75.
22. Hunchangsith P, Barendregt JJ, Vos T, Bertram M. Cost-effectiveness of different strategies for tuberculosis control programs in Thailand [abstract]. ISPOR 4th Asia-Pacific Conference, Phuket, Thailand, 5 - 7 September 2010. Value in Health 2010;13(7):A504-5.
23. Hunchangsith P, Barendregt JJ, Vos T, Bertram M. Cost-effectiveness of various tuberculosis control strategies in Thailand. Value in Health 2012;15(1 Suppl):S50-5.
24. Iribarren S, Beck S, Pearce PF, Chirico C, Etchevarria M, Cardinale D, et al.Text TB: a mixed method pilot study evaluating acceptance, feasibility, and exploring initial efficacy of a text messaging intervention to support TB treatment adherence. Tuberculosis Research and Treatment 2013;349394:1-12.
25. Jin BW, Kim SC, Mori T, Shimao T. The impact of intensified supervisory activities on tuberculosis treatment. Tubercle and Lung Disease 1993;74(4):267-72.
26. Krishna S, Balas EA, Boren SA, Maglaveras N. Patient acceptance of educational voice messages: a review of controlled clinical studies. Methods of Information in Medicine 2002;41(5):360-9.
27. Lin RL, Lin FJ, Wu CL, Peng MJ, Chen PJ, Kuo HT. Effect of a hospital-based case management approach on treatment outcome of patients with tuberculosis. Journal of the Formosan Medical Association 2006;105(8):636-44.
28. Morisky DE, Malotte CK, Choi P, Davidson P, Rigler S, Sugland B, et al.A patient education program to improve adherence rates with antituberculosis drug regimens. Health Education Quarterly 1990;17(3):253-67.
29. Morisky DE, Malotte CK, Ebin V, Davidson P, Cabrera D, Trout PT, et al.Behavioral interventions for the control of tuberculosis among adolescents. Public Health Reports 2001;116(6):568-74.
30. Nyamathi A, Stein JA, Schumann A, Tyler D. Latent variable assessment of outcomes in a nurse-managed intervention to increase latent tuberculosis treatment completion in homeless adults. Health Psychology 2007;26(1):68-76.
31. Sanneh AFNS, Pollock JI. Comparison of Pulmonary TB DOTS clinic medication before and after the introduction of daily DOTS treatment and attitudes of treatment defaulters in the Western Division of the Gambia. African Health Sciences 2010;10(2):165-71.
32. Tanke ED, Martinez CM, Leirer VO. Use of automated reminders for tuberculin skin test return. American Journal of Preventive Medicine 1997;13(3):189-92.
33. Thiam S, LeFevre AM, Hane F, Ndiaye A, Ba F, Fielding KL, et al.Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA 2007;297(4):380-6.
34. Toczek A, Cox H, du Cros P, Cooke G, Ford N. Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. International Journal of Tuberculosis and Lung Disease 2012;17(3):299-307.
35. Yusuf K. Incentives to improve tuberculosis treatment adherence. 6th EDCTP Forum: Strengthening Research Partnerships for Better Health and Sustainable Development; 2011 Oct 9-12; Addis Ababa. EDCPT, 2011:205.
36. CTRI/2011/07/001889. The development and evaluation of m-Health service in the control of Tuberculosis (TB) in India - TIMTAM trial. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=2883 (accessed 03 February 2014).
37. ISRCTN46846388. Cluster randomized trial of using mobile text messaging and a medication monitor in tuberculosis (TB) case management. http://isrctn.org/ISRCTN46846388 (accessed 20 January 2014).
38. NCT01471977. Interventions to promote adherence to tuberculosis treatment among patients attending basic medical unit of Taluka Gambat, Pakistan. http://clinicaltrials.gov/ct2/show/NCT01471977 (accessed 17 October 2012).
39. NCT01549457. A randomized controlled trial to examine the effectiveness of use of mobile phones and text messaging to improve adherence to treatment of latent TB. http://clinicaltrials.gov/show/NCT01549457 (accessed 10 February 2014).
40. NCT01690754. Evaluating the effectiveness of interactive SMS reminders on TB drug compliance and treatment. http://clinicaltrials.gov/ct2/show/NCT01690754 (accessed 17 October 2012).
41. NCT02082340. Innovative approach in tuberculosis care in Armenia. http://clinicaltrials.gov/show/NCT02082340 (accessed 31 March 2014).
42. PACTR201307000583416. Evaluation of therapeutic adherence support by SMS on the cure rate of Tuberculosis: a protocol of a randomized control study. http://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?dar=true&tNo=PACTR201307000583416 (accessed 03 February 2014).
43. Bediang G, Stoll B, Elia N, Abena JL, Nolna D, Chastonay P, et al.SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study. Trials 2014;15:35.
44. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. New England Journal of Medicine 1993;328(8):527-32.
45. Green D. ICT-enabled development case studies series: The compliance service uses SMS technology for TB treatment. http://www.comminit.com/global/content/compliance-service-uses-sms-technology-tb-treatment (accessed 21 October 2014).
46. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, GRADE Working Group. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995-8.
47. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
48. Jagota P, Sreenivas TR, Parimala N. Improving treatment compliance by observing difference in treatment irregularity. Indian Journal of Tuberculosis 1996;43:75-80.
49. Johansson E, Long NH, Diwan VK, Winkvist A. Attitudes to compliance with tuberculosis treatment among women and men in Vietnam. International Journal of Tuberculosis and Lung Disease 1999;3(10):862-8.
50. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
51. Lutge EE, Wiysonge CS, Knight SE, Volmink J. Material incentives and enablers in the management of tuberculosis. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD007952.pub2].
52. M'Imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD006591.pub2].
53. Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. International Journal of Tuberculosis and Lung Disease 1998;2(1):10-5.
54. National Tuberculosis Management Guidelines 2014. National Department of Health South Africa http://www.health-e.org.za/2014/06/10/guidelines-national-tuberculosis-management-guidelines/ (Accessed 21 October 2014).
55. Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infectious Diseases 2013;13:566.
56. O'Boyle SJ, Power JJ, Ibrahim MY, Watson JP. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). International Journal of Tuberculosis and Lung Disease 2002;6(4):307-12.
57. Ormerod LP, Prescott RJ. Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respiratory Medicine 1991;85(3):239-42.
58. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
59. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD009593.pub3].
60. Thilakavathi S, Fredrick JS, Fredrick KG, Parthasarathy R, Santha T, Somasundaram PR, et al.High coverage for long term follow-up of patients with spinal tuberculosis. Indian Journal of Tuberculosis 1993;40(2):91-4.
61. Jacobson Vann JC, Szilagyi P. Patient reminder and recall systems to improve immunization rates. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD003941.pub2].
62. Visarutrat S. Mobile phone for increase success rate of TB treatment outcome in TB patients. Chiang Mai PCMO preliminary report. Chiang Mai: Chiang Mai Provincial Health Office 2009.
63. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003343.pub3].
64. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, et al.The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. New England Journal of Medicine 1994;330(17):1179-84.
65. WHO Global Tuberculosis Programme. Treatment of tuberculosis: guidelines for national programmes [WHO/CDS/TB/2003.313]. 3rd Edition. Geneva: World Health Organization, 2003.
66. World Health Organization. Adherence to long term therapies: evidence for action. Geneva: World Health Organization, 2003.
67. The Stop TB Strategy. Geneva, World Health Organization, 2006 (WHO/HTM/TB/2006.368).
68. World Health Organization. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. http://apps.who.int/iris/bitstream/10665/44586/1/9789241501545_eng.pdf?ua=1 (accessed 21 October 2014).
69. World Health Organization. Global tuberculosis report. WHO Report 2013. WHO/HTM/TB/2013.11. Geneva: World Health Organization, 2013.